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Addition of Chiral and Achiral Allyltrichlorostannanes to Chiral α-Alkoxy Aldehydes
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Aliltricloroestananas quirais e aquirais reagem com α-alcóxi aldeídos quirais para fornecer 
alcoóis homoalílicos com moderados a bons níveis de diastereosseletividade 1,4-syn. 
Achiral and chiral allyltrichlorostannanes reacted with chiral α-alkoxy aldehydes to give the 
corresponding homoallylic alcohols with moderate to good levels of 1,4-syn-diastereoselection. 
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Introduction
Allylsilanes and allylstannanes are among the most 
important groups of organometallic-type reagents available 
for the control of acyclic stereochemistry and their reaction 
with aldehydes in the presence of Lewis acids is an important 
procedure for the preparation of homoallylic alcohols.1,2 
The addition of allylstannanes bearing a stereogenic center 
to chiral aldehydes is particularly interesting in organic 
synthesis. We recently communicated that in situ prepared 
chiral allyltrichlorostannanes react with chiral aldehydes 
to give 1,4-syn homoallylic alcohols with high levels of 
diastereoselectivity.3-11 
We wish to describe here a stereocontrolled reaction 
between achiral and chiral allyltrichlorostannanes with 
chiral lactate-derived aldehydes to give fragments which can 
be found in a large variety of naturally-occurring products 
with promising biological activities.12 This study details our 
efforts to understand the double stereodifferentiating 
stereocontrol elements involved in chiral allyltrichlorostannane 
additions to chiral aldehydes.13 
Results and Discussion
Achiral and chiral allylsilanes 1-4 were prepared 
from the corresponding easily available methyl esters, as 
described in previous papers from this laboratory (Scheme 
1).3-11,14 According to previously established experimental 







) before the addition of a solution of the 





leading to the corresponding allyltrichlorostannanes 5-8 
(Scheme 1).5
To the best of our knowledge, the first spectroscopic 
information available on exchange reactions involving 
allylsilanes and SnCl
4
 was reported by Denmark and 
co-workers in 1988.13 In 1999, we described the first direct 
evidence for interaction between SnCl
4
 and chiral allylic silane 
3 bearing an ether functionality that generated a new species 
by means of NMR spectroscopy.5 In a continuation of these 
initial studies we have done a spectroscopic study (1H and 





 leading to the corresponding 
allyltrichlorostannanes 5-8, respectively (Scheme 1).





producing allyltrichlorostannane 5 and Me
3
SiCl is complete 





 exchange to give 6 and Me
3
SiCl is faster, 
as expected for a 1,1-disubstituted electron-rich olefin, 
being complete after 10 minutes at room temperature.14 
Upon addition of SnCl
4
 to a solution of allylsilanes (R)-3 
and (S)-4 in CDCl
3
, at −60 oC, slightly yellow homogeneous 
solutions were obtained. The resulting NMR spectrum 
at −60 oC showed formation of Me
3
SiCl and complete 
consumption of both allylsilanes within less than 1 minute 
to give allyltrichlorostannanes (R)-7 and (S)-8, respectively. 





exchange reaction observed even 







 exchange is probably facilitated 
by coordination of tin to this oxygen followed by cleavage 
of the carbon-silicon bond by a free chloride ion. 
Analysis of the corresponding 1H NMR spectrum 




 in allylstannane 





exchange reaction of allylsilanes 1-4
5 when compared to the same signals for allylsilane 1 
(Table 1).5
The same trend is observed for allylstannane 6 when 
compared to allylsilane 2 (Table 2).14





 in the 1H NMR spectrum provides the best diagnostics 




 as well as 




 are too far away from 
the trichlorotin group to suffer from inductive effects. We 
believe that the deshielding observed for these hydrogens 
in (R)-7 is due to the internal coordination of this oxygen 
to tin, as proposed in Table 3.5
A similar behavior is observed for allylstannane (S)-8 
when compared to allylsilane (S)-4 (Table 4).
In addition, we have observed 119Sn resonance signals 
at −28 ppm for allylstannane 5 (Figure 1).5 The tin 
chemical shift for allylstannane (R)-7 appeared at −187 









1 4.85 4.80 5.75 1.75
5 5.45 5.35 5.95 3.25
Table 2. 1H NMR chemical shifts (δ/ppm) for 2 and 614
Compound H1 H2 H3
2 4.52 4.60 1.57
6 5.07 5.10 3.15




















(R)-3 4.57 4.54 1.46 1.52 2.20 3.18 3.46 4.43 4.48 1.04
(R)-7 5.18 5.05 3.20 3.36 2.48 3.56 3.69 4.72 4.77 0.95
Table 4. 1H NMR chemical shifts (δ/ppm) for (S)-4 and (S)-8
Compound H1 H2 H3 H4 H5 H6 H7 Me
(S)-4 4.80 5.00 1.26 1.32 3.84 4.52 4.59 1.30
(S)-8 5.01 5.05 2.91 3.05 4.17 4.65 5.10 1.28
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ppm and for allylstannane (S)-8 appeared at −169 ppm. 
The tin chemical shift for complexes 9 and 10 are −301 
ppm and −599 ppm, respectively, while for free SnCl
4
 it is 
−156 ppm. We believe that tin chemical shifts are highly 
sensitive to oxygen bonding, as observed for 9 and 10, 
and the tin chemical shifts observed for (R)-7 and (S)-8 
are strong evidence in favor of the proposed complexed 
intermediates.
The corresponding chiral aldehydes 11 and 12 
were prepared in excellent yields from methyl lactate 
(Figure 2).15,16 These substrates have been selected to 
be representative of the complex fragments that might 
be coupled in polyacetate and polypropionate-derived 
aldol-type reactions. For aldehydes 11, internal chelation 
is presumably prevented since, with few exceptions, silyl 
ethers are generally recognized for their poor coordinating 
and chelating abilities.17 
In order to check the facial selectivities of aldehydes 11 
and 12, we reacted them with achiral allyltrichlorostannanes 
5 and 6. Achiral allyltrichlorostannane 5 reacted with chiral 




 at –78 oC to give the 
corresponding 1,2-syn product 13 (anti-Felkin isomer) as 
the major isomer in 45% yield for the two-step sequence 
(preparation of the aldehyde from the ester and coupling 
reaction), with 60:40 diastereoselectivity (Scheme 2).18,19 
Achiral allyltrichlorostannane 6 addition to the same 
aldehyde gave the corresponding 1,2-syn product 15 as 
the major isomer in 40% yield for the two-step sequence, 
again with 60:40 diastereoselectivity (Scheme 2). The 
stereoinduction observed in these reactions indicates 
Figure 1. 119Sn chemical shifts (Me
4
Sn (0.0 ppm) is used as an internal reference)
Figure 2. Chiral aldehydes 11 and 12
that the intrinsic facial bias imposed by the resident 
α-OTBS substituent results in preferential formation of 
the 1,2-syn diastereomer, with a small preference for the 
anti-Felkin type approach.19 One might project that the 
transition states of these reactions exhibit less charge 
separation than the aldol processes and are, accordingly, 
less subject to the electrostatic influence of the α-OTBS 
function.
The relative stereochemistry for the major product 
13 was confirmed by comparison with data described 
in the literature.20 In addition, we have also confirmed 
the relative stereochemistry for both 13 and 15 by 
analysis of the 1H and 13C NMR chemical shifts for both 
syn and anti isomers, as described by Heathcock21 and 
Hoffmann22 for similar structures and applied to more 
complex substrates in this work. 1H NMR and 13C NMR 
spectroscopy are very useful tools to study substituent 
effects on the electronic environment of a given carbon, 
as well as to determine the relative stereochemistry in 
acyclic molecules, especially by analysis of the coupling 
constants (J) in the corresponding 1H NMR spectra. In 
the case of homoallylic alcohols 13-16, it is possible to 
assign the relative stereochemistry by 1H and 13C NMR 
analysis, as these compounds, by adopting an internal 
hydrogen-bonded conformation, exhibit magnetically 
distinct NMR environments.
The intramolecular hydrogen bond leads to a 5-member 
ring in which the substituents are trans (13 and 15) or cis 
(14 and 16) and the predominance of hydrogen-bonded 
conformations should be reflected in different 1H and 13C 
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chemical shifts (Table 5). In fact, very strong experimental 
evidence for the existence of intramolecular hydrogen 
bonds in alcohols 13-16 comes from the observed chemical 
shifts in the 1H NMR and 13C NMR spectra measured 
in CDCl
3
 (Table 5). We have shown previously that the 
intrinsic low basicity of silyl ethers does not affect the 
capacity of the oxygen attached to the silicon atom to form 
intramolecular hydrogen bonds.23 The 1H NMR spectra for 
compounds 13-16 are first order and the coupling constants 
(J) and chemical shifts (δ) are directly measured from the 





both 1,2-syn isomers 13 and 15 are more shielded than the 




 in 1,2-anti homoallylic 
alcohols 14 and 16. For alcohol 13 (R = TBS), the 1H 
chemical shifts are 3.38 (Ha) and 3.70 (Hb), showing a 
trans orientation between these two hydrogens. For alcohol 
14, the 1H chemical shifts are 3.56 (Ha) and 3.78 (Hb), 
showing a cis orientation between these two hydrogens. 
The same trend is observed for syn and anti homoallylic 
alcohols 15 and 16.
In addition, the 13C chemical shifts for the methyl group 
in syn compounds 13 and 15 are more deshielded when 
compared to the 13C chemical shifts in 14 and 16. 
We next examined the stereochemical impact of a 
benzyl-protecting group at the oxygen in position α to the 
carbonyl aldehyde. Before starting the study described in 
Scheme 3, we expected that under conditions favouring 
internal chelation, the carbonyl facial bias of aldehyde (S)-
12 should be highly predictable. In fact, that proved to be 
the case. The facial bias of aldehyde (S)-12 was determined 





−78 °C to give a 97:3 mixture of diastereoisomers 17 and 
18, in 45% yield over the two step sequence (Scheme 3).
This benzyl-protecting group imposes an intrinsic facial 
bias on the carbonyl that results in the formation of the 
Scheme 2. Addition of achiral allyltrichlorostannanes 5 and 6 to aldehyde (S)-11
Table 5. 1H NMR chemical shifts for homoallylic alcohols 13-16
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1,2-syn-dioxygen relationship. This leads to higher levels 
of diastereoselection when compared to the use of a TBS 
protecting group.
The 1,2-syn relative stereochemistry for adduct 17 was 
confirmed by comparison of 1H- and 13C NMR data as well 
as its optical rotation with literature values.24 
Previous work from our laboratory showed that 
allyltrichlorostannane (R)-7 reacted with achiral aldehydes 
leading to the formation of 1,4-syn products as the major 
isomers (up to > 95:5 diastereoselectivity).3-11 
At this point we initiated the double stereodifferentiating 
studies involving allyltrichlorostannane (R)-7 and chiral 
aldehydes 11 and 12. Addition of allyltrichlorostannane 




 at −78 °C gave 
an 85:15 mixture of diastereoisomers 19 and 20, 
respectively, in 70% yield for the two-step sequence 
(Scheme 4).
Allyltrichlorostannane (R)-7 reacted with aldehyde 
(R)-11 to give 1,4-syn-1,2-syn product 21 as the major 
product in 55% yield (2 steps), although with only 70:30 
diastereoselectivity (Scheme 4). 
The facial bias of this chiral allyltrichlorostannane is 
dominated by the α−methyl stereocenter and tends to give 
the 1,4-syn isomer with Si-face attack, but the facial bias 
of this particular aldehyde is to give the 1,2-syn product. 
We were surprised with the result with aldehyde (R)-11 as 
we were expecting a higher level of diastereoselection in 
favor of the product 21. 
The relative stereochemistry for the major products 
was determined after conversion to the corresponding 
dimethylacetonides (Scheme 5). Treatment of a mixture 
of 19 and 20 with TBAF in THF at room temperature 
gave diols 23 and 24 (67% yield), which was followed by 
reaction with 2,2-dimethoxypropane and catalytic amounts 
of camphorsulphonic acid (CSA) to give acetonides 25 
and 26 in 40% yield after purification by flash column 
chromatography (Scheme 5).
The cis- acetonide 25 comes from the 1,2-anti isomer 
19 and the trans- acetonide 26 originates from the 





) in both trans and cis dimethylacetonides 
are in different (average) chemical environments, giving 
Scheme 3. Addition of achiral allyltrichlorostannane 5 to aldehyde (S)-12
Scheme 4. Addition of allyltrichlorostannane (R)-7 to aldehydes (S)-11 and (R)-11
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rise to characteristic signals. As observed by Lombardo 





) in the five member ring of 
the dimethylacetonides is larger for the cis isomer (0.12-
0.14 ppm) when compared to the trans isomer (0.01-0.04 
ppm).25 In Figure 3 we can observe the partial 1H NMR 
for cis and trans acetonides 25 and 26 .





) in the cis isomer (∆δ = 0.12 
ppm) when compared to the chemical shifts for the same 
methyl groups of the trans isomer (∆δ = 0.05 ppm). Based 
on this result we conclude that the 1,2-anti isomer 19 is 
the major product.26
The relative stereochemistry for compounds 21 and 22 
was determined based on the same strategy (Scheme 6).
As before, we observed that the most intense signals 
come from the trans- acetonide 30, which in this case 
originates from the 1,2-syn adduct 21 (Figure 4). 
We next moved to investigate the addition of 
allyltrichlorostannane (R)-7 to enantiomeric aldehydes 12 
(Scheme 7). Allyltrichlorostannane (R)-7 reacted with chiral 




 at –78 oC to give the 
corresponding 1,2-anti product 31 as the major product in 
70% yield and with 85:15 diastereoselectivity (Scheme 7). 
Scheme 5. Preparation of acetonides 25-(cis) and 26-(trans)
Scheme 6. Preparation of acetonides 29-(trans) and 30-(cis)
Figure 3. Partial 1H NMR for acetonides 25 and 26
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The coupling reaction between allyltrichlorostannane 




 at −78 °C gave a 63:37 
mixture of diastereoisomers 33 and 34, in 60% yield for 
the two-step sequence.
It is interesting to point out that as the facial bias of 
this aldehyde is to give the 1,2-syn products, we expected a 
matched case and much higher levels of diastereoselectivity 
in the reaction of (R)-7 with (R)-12. Again, we were 
surprised to see that this was not the case.
The relative stereochemistries for both 31 and 33 were 
determined by applying the same methodology based on 
the 13C NMR chemical shifts described before for 13-16 
(Table 5). The 1,2-anti isomer is the major product as we 
Figure 4. Partial 1H NMR for acetonides 29 and 30
Scheme 7. Addition of chiral allyltrichlorostannane (R)-7 to chiral aldehydes 12
can observe from the 13C NMR chemical shifts for the 
more shielded Me
c
 (Figure 5). In the case of 31 and 32, the 
13C chemical shifts for Me
c
 in 31 appears more shielded 
(14.8 ppm) when compared to 32 (15.5 ppm).
In the case of 33 and 34, we were able to confirm that 
the 1,2-syn is the major product, based on the 13C chemical 
shifts for Me
c
 in 33 (15.5 ppm) and 34 (14.5 ppm).
At this point, we turned our attention to the coupling 
reactions involving allyltrichlorostannane (S)-8. Addition 
of allyltrichlorostannane (S)-8 to aldehyde (S)-11 gave a 
65:35 mixture of diastereoisomers 35 and 36 in 60% yield 
(2 steps) (Scheme 8). 
We next examined the addition of the same allylstannane 
to the enantiomeric aldehyde (R)-11 affording a 75:25 
mixture of isomers 37 and 38 in 47% yield for the two-
step sequence. 
Figure 5. 13C NMR chemical shifts for Me
c
 in homoallylic alcohols 
31-34 
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Again, these reactions with α-OTBS aldehydes are 
characterized by poor levels of diastereoselectivity. 
The relative stereochemistry for the major products 
was again determined based on the analysis of the 13C 
NMR chemical shifts of the corresponding 5-membered 
dimethylacetonides (Scheme 9). Treatment of 35 and 36 
with TBAF at rt followed by treatment of the corresponding 
diols under acidic conditions with 2,2-dimethoxypropane 
gave acetonides 41 and 42, respectively.
The 1H NMR methyl resonances observed at 1.34 and 
1.46 for 41 are characteristic of a cis-acetonide and 1H NMR 
methyl resonances at 1.38 and 1.40 for 42 are consistent 
with a trans-acetonide (Figure 6).25
The same strategy was applied to 37 and 38, providing 
acetonides 45 and 46 (Scheme 10).
As can be seen from Figure 7, the trans-acetonide, 
which comes from the 1,2-syn adduct is the major isomer 
observed in this reaction.
Addition of allyltrichlorostannane (S)-8 to aldehyde 




, gave an 80:20 diastereoisomeric 
mixture in favor of the 1,2-anti isomer 47 in 70% yield for 
the 2 steps (Scheme 11). Addition of allyltrichlorostannane 




, led to a 60:40 
diastereoisomeric mixture favoring the 1,2-syn isomer in 
60% yield for the 2 steps (Scheme 11).
The selectivity in the latter case was somewhat 
disappointing, given the result observed in the reaction of 
aldehyde 12 with allyltrichlorostannane 5 (Scheme 3).
The relative stereochemistries for both 47 and 49 were 
determined by applying the same methodology described 
before for 13-16 (Table 5). The 1,2-anti isomer is the 
major product as can be observed from the 13C NMR 
chemical shifts for the more shielded Me
c
 (Figure 8). In 
the case of 49 and 50, the 13C chemical shifts for Me
c
 in 
50 appears more shielded (14.7 ppm) when compared to 
49 (15.6 ppm).
Scheme 8. Addition of chiral allyltrichlorostannane (S)-8 to chiral aldehydes 11
Scheme 9. Preparation of acetonides 41-(cis) and 42-(trans)
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Figure 6. Partial 1H NMR for acetonides 41-(cis) and 42-(trans)
Scheme 10. Preparation of acetonides 45-(trans) and 46-(cis)
Figure 7. Partial 1H NMR for acetonides 45-(trans) and 46-(cis)
Scheme 11. Addition of allyltrichlorostannane (S)-8 to chiral aldehydes 12
Dias et al. 811Vol. 20, No. 4, 2009
Conclusions
The examples presented in this work show that the 
levels of π−facial selection are dependent on the absolute 
stereochemistries of the aldehydes as well as of the 
allyltrichlorostannanes. The results from these experiments 
suggest that the stereochemical relationships between 
the allyltrichlorostannane and aldehyde substituents 
may confer either a reinforcing (matched) or opposing 
(mismatched) facial bias on the carbonyl moiety. One 
possible reason for this result could be attributed to 
the involvement of energetically similar chair and 
twist-boat transition states that lead to diastereomeric 
product formation. Another possibility to consider in 
these reactions is that nonbonded interactions between 
the allyltrichlorostannane and α substituents on the 
aldehyde may not be significant in pericyclic transition 
states leading to either Felkin or anti-Felkin addition 
products.13 We believe that this chemistry is significant in 
the context of acyclic diastereoselection and will prove 
to be useful in the synthesis of more complex molecules, 
like polyacetate and polypropionate-derived natural 
products.27,28
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Figure 8. 1H NMR chemical shifts for homoallylic alcohols 47-50
References
 1.  Fleming, I.; Barbero, A.; Walter, D.; Chem. Rev. 1997, 97, 
2063; Nishigaichi, Y.; Takuwa, A.; Naruta, Y.; Maruyama, K.; 
Tetrahedron 1993, 49, 7395; Panek, J. S.; Xu, F.; Rondon, A. 
C.; J. Am. Chem. Soc. 1998, 120, 4113; Zhu, B.; Panek, J. S.; 
Eur. J. Org. Chem. 2001, 9, 1701; Huang, H. B.; Spande, T. F.; 
Panek, J. S.; J. Am. Chem. Soc. 2003, 125, 626; Keck, G. E.; 
Abbott, D. E.; Tetrahedron Lett. 1984, 25, 1883; Maguire, R. J.; 
Mulzer, J.; Bats, J. W.; J. Org. Chem. 1996, 61, 6936; Denmark, 
S. E.; Stavenger, R. A.; J. Org. Chem. 1998, 63, 9524.
 2.  Trost, B. M.; Urabe, H.; J. Org. Chem. 1990, 55, 3982; 
Nishigaishi, Y.; Takuwa, A.; Jodai, A.; Tetrahedron Lett. 
1991, 32, 2383; Almendros, P.; Gruttadauria, M.; Helliwell, 
M.; Thomas, E. J.; J. Chem. Soc. Perkin Trans. I 1997, 2549; 
Deka, D. C.; Helliwell, M.; Thomas, E. J.; Tetrahedron 2001, 
57, 10017; Martin, N.; Thomas, E. J.; Tetrahedron Lett. 2001, 
42, 8373; Kumar, P.; Thomas, E. J.; Tray, D. R.; J. Braz. Chem. 
Soc. 2001, 12, 623; Gruttadauria, M.; Thomas, E. J.; J. Chem. 
Soc. Perkin Trans. I 1995, 1469; Nishigaichi, Y.; Kuramoto, H.; 
Takuwa, A.; Tetrahedron Lett. 1995, 36, 3353.
 3.  Dias, L. C.; Giacomini, R.; J. Braz. Chem. Soc. 1998, 9, 357.
 4.  Dias, L. C.; Giacomini, R.; Tetrahedron Lett. 1998, 39, 5343.
 5.  Dias, L. C.; Meira, P. R. R.; Ferreira, E.; Org. Lett. 1999, 1, 
1335. See also: “NMR Spectra and Structures of Organotin 
Compounds,” V. S. Petrosyan, Progr. in NMR Spectr. 1978, 11, 115.
 6.  Dias, L. C.; Meira, P. R. R.; Synlett 2000, 37
 7.  Dias, L. C.; Ferreira, E.; Tetrahedron Lett. 2001, 42, 7159.
 8.  Dias, L. C.; Ferreira, A. A.; Diaz, G.; Synlett 2002, 1845.
 9.  Dias, L. C.; Diaz, G.; Ferreira, A. A.; Meira, P. R. R.; Ferreira, 
E.; Synthesis 2003, 603.
 10.  Dias, L. C.; Giacomini, R.; Meira, P. R. R.; Ferreira, E.; Ferreira, 
A. A.; Diaz, G.; dos Santos, D. R.; Steil, L. J.; Arkivoc 2003, 
10, 240.
 11.  Dias, L. C.; dos Santos, D. R.; Steil, L. J.; Tetrahedron Lett. 
2003, 44, 6861.
 12.  We have recently described a very efficient and synthetically 
useful 1,4-anti-1,5-anti boron-mediated aldol reaction of chiral 
α-methyl-β-alkoxy methyl ketone with achiral aldehydes: Dias, 
L. C.; Baú, R. Z.; de Sousa, M. A.; Zukerman-Schpector, J.; 
Org. Lett. 2002, 4, 4325. 
 13.  Denmark, S. E.; Wilson, T.; Willson, T. M.; J. Am. Chem. 
Soc. 1988, 110, 984; Denmark, S. E.; Weber, E. J.; Wilson, T.; 
Willson, T. M.; Tetrahedron 1989, 45, 1053; Denmark, S. E.; 
Almstead, N. G.; Tetrahedron 1992, 48, 5565; Denmark, S. E.; 
Almstead, N. G.; J. Am. Chem. Soc. 1993, 115, 3133.
 14.  Dias, L. C.; Fattori, J.; Perez, C. C.; Tetrahedron Lett. 2008, 
49, 557; Dias, L. C.; Fattori, J.; Perez, C. C.; Oliveira, V. M.; 
Aguilar, A. M.; Tetrahedron 2008, 64, 5891.
 15.  Kim, D.; Lee, J.; Shim, P. J.; Lim, J. I.; Doi, T.; Kim, S.; J. Org. 
Chem. 2002, 67, 772.
Addition of Chiral and Achiral Allyltrichlorostannanes to Chiral α-Alkoxy Aldehydes J. Braz. Chem. Soc.812
 16.  Although the diastereoselectivity of the reactions of these 
aldehydes with allyltrichlorostannanes depends on their 
enantiomeric purity, crude aldehydes were used in all of the 
studies described in the text.
 17.  Shambayati, S.; Schreiber, S. L.; Blake, J. F.; Wierschke, S. G.; 
Jorgensen, W. L.; J. Am. Chem. Soc. 1990, 112, 697.
 18.  The ratios were determined by 1H and 13C-NMR spectroscopic 
analysis of the purified product mixture; The syn and anti-
products could not be separated and were characterized as 
mixtures; All of the percentage values represent data obtained 
from at least three individual trials. 
 19.  Chérest, M.; Felkin, H.; Prudent, N.; Tetrahedron Lett. 1968, 18, 
2199; Anh, N. T.; Eisenstein, O.; Nouv. J. Chem. 1977, 1, 61; We 
use the “Felkin” descriptor to refer to the diastereomer predicted 
by the Felkin-Ahn paradigm. The “anti-Felkin” descriptor refers 
to diastereomers not predicted by this transition state model.
 20.  Batey, R. A.; Thadani, A. N.; Smil, D. V.; Lough, A. J.; Synthesis 
2000, 7, 990.
 21.  Heathcock, C. H.; Pirrung, M. C.; Sohn, J. E.; J. Org. Chem. 
1979, 44, 4294.
 22.  Landmann, B.; Hoffmann, R. W.; Chem. Ber. 1987, 120, 331.
 23.  Dias, L. C.; Ferreira, M. A. B.; Tormena, C. F.; J. Phys. Chem. 
A 2008, 112, 232.
 24.  Sames, D.; Liu, Y.; De Young, L.; Polt, R.; J. Org. Chem. 1995, 
60, 2153.
 25.  Lombardo, M.; Morganti, S.; Trombini, C.; J. Org. Chem. 2003, 
68, 997.
 26.  Having confirmed the relative (syn or anti) relationship 
between allylstannane-derived stereogenic centers, the 
absolute stereochemistry of the newly formed hydroxyl 
substituent was determined by ascertaining its relationship to 
the stereocenter originating from the aldehydes, which are of 
known configuration. 
 27.  All new compounds were isolated as chromatographically pure 
materials and exhibited acceptable 1H-NMR, 13C-NMR, IR, MS, 
and HRMS spectral data.
 28.  General procedure for allyltrichlorostannane coupling 
reactions: To a solution of 2.5 mmol of the corresponding 




at –78 oC was added 2.5 mmol 
of SnCl
4
. The resulting solution was stirred at –78 oC for 30 min 




was added. This 
mixture was stirred at –78 oC for 1 h and quenched by the slow 
addition of 0.2 mL of Et
3
N, followed by 10 mL of saturated 
NH
4
Cl solution. The layers were separated and the aqueous layer 




 (2x5 mL). The combined organic 
layer was dried (MgSO
4
), filtered, and concentrated in vacuo. 
Purification by flash chromatography on silica gel (30% EtOAc/
hexanes) gave the corresponding homoallylic alcohols. 
Received: February 9, 2009
Web Release Date: April 30, 2009




J. Braz. Chem. Soc., Vol. 20, No. 4, S1-S43, 2009.
Printed in Brazil - ©2009  Sociedade Brasileira de Química
0103 - 5053  $6.00+0.00
*e-mail: ldias@iqm.unicamp.br
Addition of Chiral and Achiral Allyltrichlorostannanes to Chiral α-Alkoxy Aldehydes
Luiz C. Dias*, Tatiana Augusto, Carla C. Perez and Leonardo J. Steil 
Chemistry Institute, State University of Campinas, UNICAMP, P.O. Box 6154, 13084-971 Campinas-SP, Brazil
General Informations: All reactions were carried 
out under an atmosphere of argon or nitrogen in flame-
dried glassware with magnetic stirring. Dichloromethane, 
t r iethylamine,  2,6-lut idine,  di isopropylamine, 
dimethylformamide and N-methylpyrrolidone were 
distilled from CaH
2
. Dimethyl sulfoxide was distilled 
under reduced pressure from calcium hydride and stored 
over molecular sieves. THF and toluene were distilled from 
sodium/benzophenone ketyl. Petrol refers to the fraction 
boiling between 40-60 oC. Purification of reaction products 
was carried out by flash chromatography using silica-gel 
(230-400 mesh). Analytical thin layer chromatography was 
performed on silica gel 60 and GF (5-40 µm thickness) 
plates. Visualization was accomplished with UV light 
and anisaldehyde, ceric ammonium nitrate stain or 
phosphomolybdic acid followed by heating or I
2
 staining. 
1H-NMR spectra were taken in CDCl
3
 at 300 MHz or at 500 
MHz spectrometer and are reported in ppm using solvent as 
an internal standard (CDCl
3
 at 7.26 ppm) unless otherwise 
indicated. Data are reported as (ap = apparent, s = singlet, 
d = doublet, t = triplet, q = quartet, quint = quintet, sext = 
sextet, ap t = apparent triplet, m = multiplet, br = broad, td 
= triplet of doublets, quint d = quintet of doublets, coupling 
constant(s) in Hz; integration. Proton-decoupled 13C-NMR 
spectra were taken in CDCl
3 
at 75 MHz spectrometer and 
are recorded in ppm using solvent as an internal standard 
(CDCl
3
 at 77.0 ppm) unless otherwise indicated.
Allylsilanes 2-4 (General Procedure): In a 3-necked 





g, 41.4 mmol) was heated under vacuum (1 Torr) at 160 °C 
for 12 h with vigorous stirring, resulting in the formation 
of a mobile white solid. The reaction flask was flushed 
with argon and allowed to cool to rt when anhydrous THF 
(65 mL) was added to the vigorously stirred anhydrous 
cerium(III) chloride forming a uniform white suspension, 
which was kept under stirring for 2 h. During this time, a 
separate three-necked 100 mL flask, fitted with a condenser 
and a pressure-equalizing dropping funnel, was charged 
with Mg turnings (1 g, 41.4 mmol), and the whole apparatus 
was flame dried under a flow of argon. To this flask was 




 (5.8 mL, 41.4 
mmol) in anhydrous THF (27 mL). This mixture was 
stirred for 3 h until almost all of the Mg had dissolved. The 
anhyd CeCl
3
 suspension was now cooled to –78 °C. To this 
suspension was added dropwise the previously prepared 
Grignard reagent, forming an off-white suspension, which 
was stirred at –78 °C for 2 h. At this time, a solution of 
the corresponding ester (13.8 mmol) in anhydrous THF (8 
mL) was added to the Grignard-cerium chloride complex 
dropwise over 5 min, and the resulting mixture was warmed 
gradually to r.t. When consumption of the starting ester was 
complete, as determined by TLC (3 h), the resulting grey 
solution was cooled to 0 °C and quenched by the addition of 
a sat. aq solution of NH
4
Cl (30 mL). The organic layer was 
separated, and the aqueous layer was extracted with Et
2
O 
(2 x 50 mL). The combined organic layers were washed 
with brine (2 x 50 mL) and dried (MgSO
4
). The solvent was 
removed under reduced pressure to give a slightly yellow 




 (100 mL). To this 
flask was added Amberlyst 15 (1.0 g) and this mixture was 
stirred at rt until complete consumption of starting material. 





 (100 mL). The solvent was removed under reduced 
pressure to give allylsilanes 2-4. 
Trimethyl(2-methylenepentadecyl)silane (2): yellow 
oil; Yield: 68%; TLC: R
f
 0.75 (EtOAc/hexane 20%); IR 
(Film): ν 3072, 2953, 2926, 2854, 1633, 1466, 1248, 1157 
cm-1; 1H NMR (CDCl
3
, 300 MHz): d 0.04 (s, 9H), 0.91 (t, 
J = 7.0 Hz, 3H), 1.29 (brs, 20H), 1.39-1.49 (m, 2H), 1.57 
(s, 2H), 1.97 (t, J = 7.0 Hz, 2H), 4.52 (brs, 1H), 4.60 (d, J 
= 1.0 Hz, 1H); 13C NMR (CDCl
3
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(R)-(4-(benzyloxy)-3-methyl-2-methylenebutyl)
trimethylsilane (3): Yield: 88%; Rf = 0.38 (EtOAc/hexanes 
5%); [α]
D
22: +12.6 (c 1.3, CHCl
3
); IR (film) ν (cm-1): 3069, 
3030, 2957, 2851, 1632, 1497, 1453, 1414, 1364, 1247, 
1158, 1097, 1031, 952, 852, 735, 696, 634 cm-1; 1H NMR 
(CDCl
3
, 300 MHz) d (ppm): 0.03 (s, 9H), 1.04 (d, J = 6.8 
Hz, 3H), 1.46 (d, J = 13.6 Hz, lH), 1.52 (d, J = 13.6 Hz, 
lH), 2.28 (m, lH), 3.26 (dd, J = 9.3, 8.3 Hz, 1H), 3.53 (dd, 
J = 9.3, 5.4 Hz, lH), 4.52 (d, J = 12.1 Hz, lH), 4.53 (d, J = 
12.1 Hz, lH), 4.62 (s, lH), 4.64 (s, lH), 7.25-7.40 (m, 5H); 
13C NMR (CDCl
3
, 75 MHz), d (ppm): −1.3, 17.1, 26.6, 
41.0, 72.9, 75.0, 106.5, 127.4, 127.5, 128.3, 138.7, 149.7; 




OSi: C, 73.22%; H, 
9.98%; found: C, 73.15%; H, 10.02%.
(S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane 
(4): Rf = 0.34 (EtOAc/hexanes 5%); [α]
D
22: +12.6 (c 1.3, 
CHCl
3
); IR (film) ν (cm-1): 3068, 3023, 2951, 1720, 1603, 
1495, 1454, 1248, 1093; 1H NMR (CDCl
3
, 300 MHz), d 
(ppm): 0.08 (s, 9H), 1.30 (d, J = 6.6 Hz, 3H), 1.48 (d, J = 
14.5 Hz, 1H), 1.62 (d, J = 14.5 Hz, 1H), 3.84 (q, J = 6.6 
Hz, 1H), 4.35 (d, J = 11.7 Hz, 1H), 4.57 (d, J = 11.7 Hz, 
1H), 4.80 (s, 1H), 5.00 (s, 1H), 7.25-7.40 (m, 5H); 13C NMR 
(CDCl
3
, 75 MHz), d (ppm): −0.8, 20.6, 21.1, 70.0, 78.8, 
108.7, 127.2, 127.5, 128.2, 138.8, 147.6. 
Allyltrichlorostannane (5): 1H NMR (CDCl
3
, 300 
MHz) d (ppm): 3.06 (d, J = 5,2 Hz, lH), 5.33 (d, J = 5.6 
Hz, lH), 5.40 (d, J = 6.6 Hz, 1H), 5.97 (m, lH); 13C NMR 
(CDCl
3
, 75 MHz) d (ppm): 35.0, 121.0, 127.0. Obs. The 
signal at 0.45 ppm corresponds to TMSCl.
Trichloro(2-methylenepentadecyl)stannane (6): 1H 
NMR (CDCl
3
, 300 MHz): d 0.89 (t, J = 6.0 Hz, 3H), 1.30 
(brs, 20H), 1.51 (m, 2H), 2.14 (t, J = 8.0 Hz, 2H), 3.15 (s, 
2H), 5.07 (brs, 1H), 5.10 (brs, 1H). Obs. The signal at 0.45 
ppm corresponds to TMSCl.
(R)-(4-(benzyloxy)-3-methyl-2-methylenebutyl)
trichlorostannane (7): 1H NMR (CDCl
3
, 300 MHz) d 
(ppm): 0.95 (d, J = 7.0 Hz, 3H), 2.48 (m, lH), 3.19 (d, J = 
11.2 Hz, lH), 3.36 (d, J = 11.2 Hz, lH), 3.53 (dd, J = 9.9, 
8.4 Hz, 1H), 3.70 (dd, J = 9.9, 4.4 Hz, lH), 4.71 (d, J = 13.2 
Hz, lH), 4.77 (d, J = 13.2 Hz, lH), 5.04 (s, lH), 5.18 (s, lH), 
7.30-7.50 (m, 5H). Obs. The signal at 0.45 ppm corresponds 
to TMSCl; 13C NMR (CDCl
3
, 75 MHz) d (ppm): 15.7, 39.9, 
42.7, 73.0, 74.5, 114.6, 127.5, 128.3, 128.7, 138.7, 144.0. 
Obs. The signal at 3.6 ppm corresponds to TMSCl.
( S ) - ( 3 - ( b e n z y l o x y ) - 2 - m e t h y l e n e b u t y l )
trichlorostannane (8): 1H NMR (CDCl
3
, 300 MHz, 
−60 ºC) d (ppm): 1.28 (d, J = 6.6 Hz, 3H), 2.91 (d, J = 
14.5 Hz, 1H), 3.05 (d, J = 14.5 Hz, 1H), 4.17 (q, J = 6.6 
Hz, 1H), 4.68 (d, J = 11.7 Hz, 1H), 5.01 (s, 1H), 5.05 (s, 
1H), 5.10 (d, J = 11.7 Hz, 1H), 7.20-7.40 (m, 5H). Obs. 
The signal at 0.45 ppm corresponds to TMSCl.
Homoallylic Alcohols (General Procedure): To a 





 (5 mL) at rt was added SnCl
4
 (1.1 mmol). The 
resulting solution was stirred at rt for 2 h and then cooled to 





(2 mL) was added. This mixture was stirred for 2 h at –78 
°C and quenched by the slow addition of a sat. aq solution 
of NaHCO
3




 (5 mL). The layers 





 (2 x 5 mL). The combined organic layers were dried 
(MgSO
4
), filtered, and concentrated in vacuo. Purification 
by flash chromatography on silica gel (30% EtOAc–hexane) 
gave the corresponding homoallylic alcohols.
(2S,3S)-2-(tert-butyldimethylsilyloxy)hex-5-en-3-ol 
(13) and (2S,3R)-2-(tert-butyldimethylsilyloxy)hex-5-en-
3-ol (14): Yield: 45%; Rf = 0.26 (EtOAc/hexanes 5%); IR 
(film) ν (cm-1): 3568, 3468, 2956, 2957, 2932, 2858, 1641, 
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1473, 1389, 1074, 1005, 968, 912, 777; 1H NMR (CDCl
3
, 
300 MHz) d (ppm): 0.08 (s, 3H), 0.09 (s, 3H), 0.91 (s, 9H), 
1.17 (d, J = 6.2 Hz, 3H), 2.18-2.32 (m, 2H), 3.33-3.43 (m, 
1H), 3.70-3.82 (m, 1H), 5.01-5.16 (m, 2H), 5.81-5.59 (m, 
1H). Minor isomer: 0.07 (s, 3H), 1.12 (d, J = 6.2 Hz, 3H), 
3.53-3.60 (m, 1H), 3.76-3.82 (m, 1H); 13C NMR (CDCl
3
, 75 
MHz) d (ppm): −4.7, −4.0, 18.2, 20.2, 25.9, 38.1, 70.9, 75.2, 
116.8, 135.1; Minor isomer (14): 17.5, 36.8, 74.5, 117.2.
(2S , 3S ) -2 - ( t e r t -buty ld imethyls i ly loxy) -5-
methyleneoctadecan-3-ol (15) and (2S,3R)-2-(tert-
butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (16): 
Yield: 40%; Rf = 0.36 (EtOAc/hexane 5%); IR (film) ν 
(cm-1): 3465, 3067, 2957, 2930, 2857, 1645, 1371, 1255, 
1092, 835, 775; 1H NMR (CDCl
3
, 300 MHz) d (ppm): 0.08 ( 
s, 6H), 0.88 (m, 3H), 0.89 (s, 9H), 1.16 (d, J = 6.0 Hz, 3H), 
1.25 (brs, 22H), 1.36-1.49 (m, 2H), 2.01-2.18 (m, 2H), 3.49 
(dq, J = 4.4 Hz, 6.6 Hz, 1H), 3.66-3.75 (m,1H), 4.81 (d, J 
= 4.7 Hz, 2H); Minor isomer: 0.06 (s, 6H), 1.12 (d, J = 6.0 
Hz, 3H), 3.56-3.66 (m,1H); 13C NMR (CDCl
3
, 63 MHz) d 
(ppm): −4.8, −4.1, 14.1, 18.0, 22.7, 25.8, 27.7, 29.4, 29.7, 
31.9, 71.0, 73.4, 111.3. Minor isomer: 20.0, 29.7, 73.0.
(2S,3S)-2-(benzyloxy)hex-5-en-3-ol (17) and (2S,3R)-
2-(benzyloxy)hex-5-en-3-ol (18): Yield: 40%; Rf = 0.44 
(EtOAc/hexane 10%); IR (film) ν (cm-1): 3566, 3453, 3062, 
3030, 2969, 2871, 1603, 1645, 1454, 1072, 1028, 993, 914, 
737, 698; 1H NMR (CDCl
3
, 500 MHz) d (ppm): 1.21 (d, J 
= 6.0 Hz, 3H), 2.15-2.26 (m, 1H), 2.31-2.40 (m, 1H), 3.44 
(apqt, J = 6.2 Hz, 1H), 3.52 (ddd, J = 4.4 Hz, 6.2 Hz, 7.7 
Hz, 1H), 4.38 (d, J = 11.7 Hz, 1H), 4.66 (d, J = 11.7 Hz, 
1H), 5.09 (d, J = 9.5 Hz, 1H), 5.12(d, J = 20.3 Hz, 1H), 
5.87 (ddt, J = 7.3 Hz, 9.5 Hz, 20.5 Hz), 7.26-7.38 (m, 5H). 
Minor isomer: 1.15 (d, J = 6.2 Hz, 3H); 13C NMR (CDCl
3
, 
63 MHz) d (ppm): 15.4, 37.5, 71.0, 74.2, 117.2, 127.8, 
128.4, 134.7, 138.3. Minor isomer: 13.8, 36.9, 70.7. 
( 2 S , 3 R , 6 R ) - 7 - ( b e n z y l o x y ) - 2 - ( t e r t -
butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-
3-ol (19) and (2S,3S,6R)-7-(benzyloxy)-2-(tert-
butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-
3-ol (20): Yield: 55%; Rf = 0.28 (EtOAc/hexanes 10%); IR 
(film) ν (cm-1): 3465, 3067, 2957, 2930, 2857, 1645, 1371, 
1092, 835, 775; 1H NMR (CDCl
3
, 300 MHz) d (ppm): 0.08 
(s, 6H), 0.9 (s, 9H), 1.07 (d, J = 7.0 Hz, 3H), 1.15 (d, J = 
6.2 Hz, 3H), 2.07 (dd, J = 9.2, 14.3 Hz, 1H), 2.31 (dd, J 
= 4.0, 14.3 Hz, 1H), 2.50 (m, 1H), 3.39 (dd, J = 6.6, 9.2 
Hz, 2H), 3.42 (dd, J = 7.0, 9.2 Hz, 2H), 3.63 (m, 1H), 3.72 
(m, 1H), 4.93 (s, 1H), 4.95 (s, 1H), 7.26-7.32 (m, 5H); 13C 
NMR (CDCl
3
, 75 MHz) d (ppm): −4.6, −4.2, 17.5, 18.1, 
18.7, 25.9, 38.7, 39.3, 71.4, 73.0, 73.5, 74.5, 111.6, 127.4, 
128.2, 138.2, 149.0.
( 2 S , 6 R ) - 7 - ( b e n z y l o x y ) - 6 - m e t h y l - 5 -
methyleneheptane-2,3-diols (23) and (24): Yield: 67%; 
Rf = 0.26 (EtOAc/hexanes 50%); 1H NMR (CDCl
3
, 300 
MHz) d (ppm): 1.02 (d, J = 7.0 Hz, 3H), 1.17 (d, J = 6.2 
Hz, 3H), 2.13-2.29 (m, 2H), 2.51-2.55 (m, 1H), 3.39-3.51 
(m, 2H), 3.70-3.77 (m, 1H), 3.84-3.92 (m, 1H) 4.51 (s, 2H), 
5.00 (s, 2H); 5.30 (s, 2H), 7.28-7.38 (m, 5H); 13C NMR 
(CDCl
3
, 75 MHz) d (ppm): 17.5, 36.8, 39.0, 69.9, 72.0, 
73.1, 74.3, 112.8, 127.8, 128.2, 137.8, 148,8. 




Rf = 0.72 (EtOAc/hexanes 20%); IR (film) ν (cm-1): 
3047, 2986, 2934, 2872, 1645, 1454, 1377, 1223, 1080; 
1H NMR(CDCl
3
, 300 MHz) d (ppm): 1.02 (d, J = 6.4 
Hz, 3H), 1.12 (d, J = 6.7 Hz, 3H), 1.31 (s, 3H), 1.49 (s, 
3H), 2.07 (dd, J = 4.9, 15.6 Hz, 1H), 2.34 (dd, J = 8.4, 
15.6 Hz, 1H), 2.07 (st, J = 6.7 Hz, 1H), 3.25 (dd, J = 7.2, 
8.9 Hz, 1H), 3.43 (dd, J = 5.8, 8.9 Hz, 1H), 4.09 (qt, J = 
6.4 Hz, 1H), 4.21 (dt, J = 5.3, 8.5 Hz, 1H), 4.33 (s, 2H), 
4,93 (d, J = 13.7 Hz, 2H), 7.28-7.38 (m, 5H); 13C NMR 
(benzene-d6, 75 MHz) d (ppm): 16.1, 17.4, 26.0, 28.9, 
35.9, 40.4, 73.1, 74.0, 75.1, 76.9, 107.4, 110.7, 126.5, 
127.6, 128.5, 139.3, 149.3.
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( 2 R , 3 R , 6 R ) - 7 - ( b e n z y l o x y ) - 2 - ( t e r t -
butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-
3-ol (21) and (2R,3S,6R)-7-(benzyloxy)-2-(tert-
butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-
3-ol (22): Rf = 0.53 (hexanes: EtOAc, 95:05); IR (film) ν 
(cm-1): 3463, 3031, 2950, 2857, 1645, 1559, 1497, 1455, 
1255, 1092, 895; 1H NMR (CDCl
3
, 300 MHz) d (ppm): 
0.09 (s, 3H), 0.09 (s, 3H), 0.91 (s, 9H), 1.09 (d, J = 7.0 
Hz, 3H), 1.16 (d, J = 6.2 Hz, 3H) 2.03-2.35 (m, 2H); 2.50 
(qt, J = 7.0 Hz,1H), 3.32-3.39 (m, 1H), 3.45-3.64 (m, 
2H), 3.72-3.80 (m, 1H), 4.52 (s, 2H), 4.91 (s, 1H), 4.94 (s, 
1H), 7.33-7.34 (m, 5H).Minor isomer: 0.07 (s, 3H), 0.08 
(s, 3H), 0.90 (s, 9H), 1.11 (d, J = 2.2 Hz, 3H); 13C NMR 
(CDCl
3
, 75 MHz) d (ppm): −4.8, −4.2, 17.4, 18.0, 18.3, 
19.7, 25.8, 38.9, 39.4, 71.0, 73.0, 79.7, 74.6, 111.4, 127.5, 
128.3, 138.4, 149.2. Minor isomer: 17.2, 38.5, 39.6, 71.4, 
74.8, 79.7, 74.6, 111.8.
( 2 R , 6 R ) - 7 - ( b e n z y l o x y ) - 6 - m e t h y l - 5 -
methyleneheptane-2,3-diol (27) and (28): Rf = 0.65 
(EtOAc/hexanes 50%); 1H NMR (CDCl
3
, 500 MHz) d (ppm): 
1.01 (d, J = 7.0 Hz, 3H), 1.18 (d, J = 6.0 Hz, 3H); 2.02-2.57 
(m, 3H); 3.87-3.34 (m, 4H) 4.49 (d, J = 2.3 Hz, 1H), 4.97 (d, 
J = 2.3 Hz, 1H), 7.28-736 (m, 5H). Minor isomer: 1.08 (d, J 
= 7.0 Hz, 3H), 1.15 (d, J = 6.0 Hz, 3H); 13C NMR (CDCl
3
, 
125 MHz) d (ppm): 17.8, 19.0, 38.5, 40.1, 70.7, 73.2, 74.8, 
113.0, 127.8, 128.4, 138.0, 148.8. Minor isomer: 17.3, 37.3, 
39.7, 69.9, 75.0, 112.7, 127.7, 128.4.




Yield: 50%; Rf = 0.38 (EtOAc/hexanes 5%); IR (film) ν 
(cm-1): 3055, 2986, 2936, 2874, 1645, 1454, 1379, 1090, 




, 500 MHz) d (ppm): 1.10 (d, 
J = 6.1 Hz, 3H), 1.13 (d, J = 7.0 Hz, 3H), 1,40 (s, 6H), 
2.13 (dd, J = 4.0, 15.0 Hz, 1H), 2.32 (dd, J = 7.6, 15.0 
Hz, 1H), 2.55 (apsex, J = 6.4 Hz, 1H), 3.23 (dd, J = 7.3, 
8.8 Hz, 1H), 3.42 (dd, J = 5.8, 8.8 Hz, 1H), 3.62 (dq, J = 
5.8, 8.2 Hz, 1H), 3.68-3.72 (m,1H), 4.33 (s, 2H), 4.91 (s, 
2H), 4.91 (s, 1H), 5.02 (s, 1H), 7.15-7.31 (m, 5H). Minor 
isomer: 1.11 (d, J = 6.0 Hz, 3H), 1.31 (s, 3H), 1.49 (s, 
3H), 2.06 (dd, J = 4.6, 15.4 Hz, 1H), 4.20 (m,1H), 4.25 




, 125 MHz) 
d (ppm): 17.2, 17.8, 27.5, 27.6, 39.0, 40.0, 73.1, 75.1, 
77.3, 81.6, 111.5, 128.0, 128.5, 139.3, 149.0. Minor 
isomer: 16.0, 17.4, 26.0, 28.9, 35.7, 40.2, 74.0, 75.0, 76.4, 
108.0, 110.8.
(2S , 3R , 6R ) -2 ,7 -b i s (benzy loxy) -6 -methy l -
5-methyleneheptan-3-ol (31) and (2S,3S,6R)-2,7-
bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (32): 
Yield: 70%; Rf = 0.36 (EtOAc/hexanes 20%); IR (film) ν 
(cm-1): 3454, 3061, 3026, 2970, 2872, 1643, 1498, 1454, 
1367, 1264, 1090; 1H NMR (CDCl
3
, 250 MHz) d (ppm): 
1.04 (d, J = 7.0 Hz, 3H), 1.22 (d, J = 6.3 Hz, 3H), 2.09-
2.53 (m, 3H), 3.33- 3.54 (m, 3H), 3.80-3.88 (m, 1H), 4.50 
(s, 2H), 4.52 (d, J = 12.0 Hz, 1H), 4.63 (d, J = 12.0 Hz, 
1H), 4.93 (s, 1H), 4.97 (s, 1H), 7.29-7.35 (m, 10H). Minor 
isomer: 1.09 (d, J = 7.0 Hz, 3H), 1.17 (d, J = 6.0 Hz, 3H), 
3.62-3.72 (m, 1H), 4.00-4.10 (m, 1H); 13C NMR (CDCl
3
, 
63 MHz) d (ppm): 14.8, 17.5, 39.0, 70.9, 73.0, 74.5, 112.0, 
127.5, 127.7, 128.3, 138.1, 149.0. Minor isomer: 15.5, 17.2, 
71.0, 71.7, 74.9, 138.7.
(2R ,3R ,6R)-2,7-bis(benzyloxy)-6-methyl-5-
methyleneheptan-3-ol (33) and (2R,3S,6R)-2,7-
bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (34): 
Yield: 60%; Rf = 0.18 (EtOAc/hexanes 10%); IR (film) ν 
(cm-1): 3695, 3055, 2976, 2930, 1715, 1452, 1072, 897; 1H 
NMR (CDCl
3
, 250 MHz) d (ppm): 1.06 (d, J = 7.0 Hz, 3H), 
1.21 (d, J = 6.0 Hz, 3H), 2.08-2.71 (m, 3H), 3.31-3.55 (m, 
3H), 3.65-3.76 (m, 1H), 4.48 (d, J = 9.2 Hz, 1H), 4.51 (s, 
2H), 4.66 (d, J = 11.3 Hz, 1H), 4.92 (s, 1H), 4.94 (s, 1H), 
7.10-7.37 (m, 10H). Minor isomer: 1.20 (d, J = 6.3 Hz, 3H), 
3.79-3.87 (m, 1H), 4.00-4.10 (m, 1H); 13C NMR (CDCl
3
, 
63 MHz) d (ppm): 15.5, 17.4, 38.8, 39.1, 39.5, 71.1, 72.6, 
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74.5, 111.8, 127.7, 128.3, 138.3, 148.9. Minor isomer: 14.5, 
17.2, 38.7, 70.8, 72.0, 74.8, 112.0, 126.0.
( 2 S , 3 R , 6 S ) - 6 - ( b e n z y l o x y ) - 2 - ( t e r t -
butyldimethylsilyloxy)-5-methyleneheptan-3-ol (35) and 
(2S,3S,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-
5-methyleneheptan-3-ol (36): Yield: 35%; Rf = 0.17 
(EtOAc/hexanes 5%); IR (film) ν (cm-1): 3564, 3445, 
3052, 2955, 2931, 2858, 1651, 1454, 1372, 1092; 1H NMR 
(CDCl
3
, 500 MHz) d (ppm): 0.08 (s, 3H); 0.09 (s, 3H); 0.90 
(s, 9 H); 1.16 (d, J = 6.2 Hz, 3H); 1.31 (d, J = 6.6 Hz, 3H); 
2.03-2.34 (m, 2H); 3.55 (dq, J = 3.3, 1.5 Hz, 1H); 3.71-3.81 
(m, 1H); 3.95-4.03 (m, 1H); 4.36 (d, J = 11.7 Hz, 1H); 4.56 
(d, J = 11.7 Hz, 1H); 5.07 (s, 1H); 5.12 (s, 1H); 7.27-7.33 
(m, 5H). Minor isomer: 0.07 (s, 3H); 0.08 (s, 3H); 0.89 (s, 
9 H); 1.13 (d, J = 5.9 Hz, 3H); 1.32 (d, J = 6.2 Hz, 3H); ); 
4.36 (d, J = 11.7 Hz, 1H); 4.53 (d, J = 11.7 Hz, 1H); 5.10 




, 75 MHz) d (ppm): 
-4.7, -4.2, 18.2, 19.2, 20.5, 26.0, 34.7, 70.2, 71.6, 74.9, 78.9, 
113.7, 114.1, 127.8, 128.5, 139.2, 148.0. Minor isomer: 
−4.6, −4.3, 18.5, 21.2, 72.1, 74.6, 79.1.
( 2 R , 3 R , 6 S ) - 6 - ( b e n z y l o x y ) - 2 - ( t e r t -
butyldimethylsilyloxy)-5-methyleneheptan-3-ol (37) and 
(2R,3S,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-
5-methyleneheptan-3-ol (38): Yield: 47%; Rf = 0.25 
(EtOAc/hexanes 10%); IR (film) ν (cm-1): 3564, 3435, 
3052, 2960, 2931, 2862, 1647, 1454, 1371, 1090; 1H NMR 
(CDCl
3
, 250 MHz) d (ppm): 0.09 (s, 6H), 0.90 (s, 9 H), 
1.16 (d, J = 6.3 Hz, 3H), 1.31 (d, J = 6.6 Hz, 3H), 2.03-
2.49 (m, 2H), 3.57 (dq, J = 4.1, 1.3 Hz, 1H), 3.65-3.76 (m, 
1H), 3.92-4.05 (m, 1H), 4.36 (d, J = 11.7 Hz, 1H), 4.52 
(d, J = 11.7 Hz, 1H), 5.10 (d, J = 1.6 Hz, 1H), 5.14 (s, 
1H), 7.26-7.35 (m, 5H). Minor isomer: 0.08 (s, 3H), 0.89 
(s, 9H), 1.15 (d, J = 6.3 Hz, 3H), 1.32 (d, J = 6.6 Hz, 3H), 
4.36 (d, J = 11.7 Hz, 1H), 4.53 (d, J = 11.7 Hz, 1H), 5.07 
(d, J = 1.6 Hz, 1H); 13C (CDCl
3
, 63 MHz) d (ppm): −4.8, 
−4.2, 18.0, 20.0, 20.1, 25.8, 35.3, 70.0, 71.5, 74.3, 78.4, 
113.2, 127.7, 128.4, 138.7, 147.2; Minor isomer: 18.6, 
20.3, 34.3, 74.6, 114.1. 
(2S,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol 
(39) and (40): Yield: 67%; Rf = 0.36 (EtOAc/hexanes 50%); 
1H NMR (CDCl
3
, 300 MHz) d (ppm): 1.18 ( d, J = 6.6 Hz, 
3H), 1.32 (d, J = 6.6 Hz, 3H), 2.14-2.45 (m, 2H), 3.61 (dt, 
J = 3.7, 8.8 Hz, 1H), 3.70 (br, 2H), 3.79-3.87 (m, 1H), 
4.00 (q, J = 6.6 Hz, 1H), 4.41 (d, J = 11.7, 1H), 4.56 (d, J 
= 11.7, 1H), 5.07 (s, 1H), 5.10 (s, 1H), 7.27-7.37 (m, 5H). 
Minor isomer: 1.19 (d, J = 6.0 Hz, 3H), 1.33 (d, J = 6.6 
Hz, 3H); 13C NMR (CDCl
3
, 75 MHz) d (ppm): 17.4, 19.9, 
33.6, 70.1, 74.6, 78.7, 115.9, 127.7, 128.5, 137.8, 146.8. 
Minor isomer: 19.2, 19.4, 35.6, 70.3, 78.5.
(4R,5S)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-
2,2,5-trimethyl-1,3-dioxolane (41) and (4S,5S)-4-((S)-
3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-
dioxolane (42): Yield: 50%; Rf = 0.55 (EtOAc/hexanes 
20%); IR (film) ν (cm-1): 3055, 2986, 2934, 2872, 1647, 




, 300 MHz) d (ppm): 1.01 
(d, J = 6.2 Hz, 3H), 1.28 (d, J = 6.6 Hz, 3H), 1.31 (s, 3H), 
1.48 (s, 3H), 2.10-2.33 (m, 2H), 3.55-3.93 (m, 1H), 3.91 
(q, J = 6.6 Hz, 1H), 4.06 (apquint, J = 6.2 Hz, 1H), 4.30 
(d, J = 12.0 Hz, 1H), 4.53 (d, J = 12.0 Hz, 1H), 5.10 (s, 
1H), 5.14 (s, 1H), 7.07-7.37 (m, 5H). Minor isomer: 1.08 
(d, J = 5.9 Hz, 3H), 1.39 (s, 3H), 1.41 (s, 3H), 3.75 (ddd, 





75 MHz) d (ppm): 15.9, 20.6, 27.5, 27.6, 31.4, 70.1, 74.0, 
76.9, 77.2, 81.1, 107.4, 112.9, 139.6, 147.1. Minor isomer: 
17.6, 26.0, 28.9, 33.4, 78.9, 78.6, 108.0, 113.2.
(2R,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol 
(43) and (44): Yield: 90%; Rf = 0.40 (EtOAc/hexanes 
50%); IR (film) ν (cm-1): 3416, 3069, 2976, 2930, 2867, 
1722, 1647, 1454, 1371, 1275, 1070; 1H NMR (CDCl
3
, 
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300 MHz) d (ppm): 1.19 (d, J = 6.6 Hz, 3H), 1.34 (d, J = 
6.6 Hz, 3H), 2.14-2.27 (m, 2H), 2.40 (d, J = 3.3 Hz, OH), 
3.49-3.55 (m, 1H), 3.61 (apqt, J = 6.2 Hz, 1H), 4.01 (q, J 
= 6.6 Hz, 1H), 4.44 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 12.0 
Hz, 1H), 5.05 (s, 1H), 5.14 (s, 1H), 7.26-7.37 (m, 5H). 
Minor isomer: 1.18 (d, J = 6.6 Hz, 3H), 1.32 (d, J = 6.6 
Hz, 3H), 2.44 (d, J = 3.3 Hz, OH), 3.80-3.88 (m, 1H), 5.11 
(s, 1H); 13C NMR (CDCl
3
, 75 MHz) d (ppm): 19.3, 19.5, 
35.7, 70.3, 74.3, 78.5, 115.4, 127.7, 128.4, 137.8, 145.9. 
Minor isomer: 17.5, 20.0, 74.6, 78.7.
(4R,5R)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-
2,2,5-trimethyl-1,3-dioxolane (45) and (4S,5R)-4-((S)-
3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-
dioxolane (46): Yield: 90%; Rf = 0.27 (EtOAc/hexanes 
5%); IR (film) ν (cm-1): 3053, 2963,2936, 2874, 1724, 
1649, 1454, 1379, 1265, 1089, 912, 842; 1H NMR (CDCl
3
, 
300 MHz) d (ppm): 1.26 (d, J = 6.0 Hz, 3H), 1.31 (d, J = 
6.6 Hz, 3H), 1.39 (s, 6H), 2.13-2.38 (m, 2H), 3.68-3.79 
(m, 1H), 3.95-4.09 (m, 1H), 4.31-4.41 (m, 1H), 4.33 (d, 
J = 12.0 Hz, 1H), 4.50 (d, J = 12.0 Hz, 1H), 5.15 (s, 2H), 
7.23-7.36 (m, 5H); Minor isomer: 0.99 (d, J = 6.6 Hz, 3H), 
1.17 (d, J = 6.2 Hz, 3H), 1.35 (s, 3H), 1.46 (s, 3H), 5.06 
(s, 2H); 13C NMR (CDCl
3
, 75 MHz) d (ppm): 17.9, 20.5, 
27.6, 33.5, 70.2, 78.7, 81.2, 108.1, 113.7, 127.8, 128.5, 
138.8, 146.6. Minor isomer: 16.1, 19.5, 26.1, 28.9, 30.8, 
72.0, 74.0, 76.2, 112.9, 115.1.
(2S,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-
3-ol (47) and (2S ,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (48): Yield: 70%; Rf = 0.55 
(EtOAc/hexanes 20%); IR (film) ν (cm-1): 3695, 3055, 
2986, 2930, 2685, 1715, 1603, 1452, 1265, 1072, 744; 1H 
NMR (CDCl
3
, 250 MHz) d (ppm): 1.20 (d, J = 6.3 Hz, 3H), 
1.32 (d, J = 6.6 Hz, 3H), 2.12-2.46 (m, 2H), 3.51 (ddd, J 
= 4.3, 6.3, 12.6 Hz, 1H), 3.87-4.13 (m, 2H), 4.37 (d, J = 
12.0, 1H), 4.49 (d, J = 11.7 Hz, 1H), 4.51 (d, J = 11.7 Hz, 
1H), 4.61 (d, J = 11.7 Hz, 1H), 5.08 (s, 1H), 5.14 (s, 1H), 
7.26-7.37 (m, 10H). Minor isomer: 1.22 (d, J = 6.3 Hz, 1H); 
13C NMR (CDCl
3
, 63 MHz) d (ppm): 14.1, 19.9, 34.1, 70.7, 
72.0, 77.5, 78.5, 114.0, 127.6, 128.4, 138.6, 146.7.Minor 
isomer: 15.2, 20.3, 34.5, 70.0, 71.0, 73.3, 78.4, 79.4, 114.2, 
127.5, 126.9, 138.5, 146.9.
(2R,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-
3-ol (49) and (2R,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (50): Yield: 88%; Rf = 0.55 (EtOAc/
hexanes 10%); 1H NMR (CDCl
3
, 250 MHz) d (ppm): 1.22 
(d, J = 6.3 Hz, 3H), 1.32 (d, J = 6.3 Hz, 3H), 2.11-2.42 (m, 
1H), 3.42-3.54 (m,1H), 3.68-3.83 (m,1H), 3.93- 4.08 (m, 
1 H), 4.34- 4.69 (m, 4H), 5.09 (d, J = 15 Hz, 1H), 5.14 (d, 
J = 5.4 Hz, 1H), 7.23-7.35 (m, 10H). Minor isomer: 1.23 
(d, J = 6.3 Hz, 1H); 13C NMR (CDCl
3
, 63 MHz) d (ppm): 
15.6, 20.2, 34.9, 70.0, 71.1, 73.4, 77.8, 78.4, 113.5, 127.7, 
127.8, 128.3, 128.4, 138.6, 146.9. Minor isomer: 14.7, 34.7, 
70.9, 73.0, 114.6, 127.4, 127.5, 138.3.
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Figure 1S. 1H NMR (CDCl
3
, 300 MHz) - (R)-(4-(benzyloxy)-3-methyl-2-methylenebutyl)trichlorostannane (7).
Figure 2S. 13C NMR (CDCl
3
, 75 MHz) - (R)-(4-(benzyloxy)-3-methyl-2-methylenebutyl)trichlorostannane (7).
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Figure 3S. 1H NMR (CDCl
3
, 300 MHz) - (S)-(3-(benzyloxy)-2-methylenebutyl)trichlorostannane (8).
Figure 4S. 1H NMR (CDCl
3
, 300 MHz) - Trichloro(2-methylenepentadecyl)stannane (6).
Dias et al. S9Vol. 00, No. 00, 2009
Figure 5S. 1H NMR (CDCl
3
, 300 MHz).
Figure 6S. 13C NMR (CDCl
3
, 75 MHz).
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Figure 7S. IR (film).
Figure 8S. 1H NMR (CDCl
3
, 300 MHz) - (R)-(4-(benzyloxy)-3-methyl-2-methylenebutyl)trimethylsilane (3).
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Figure 9S. 13C NMR (CDCl
3
, 75 MHz) - (S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane (4).
Figure 10S. IR (film) - (S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane (4).
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Figure 11S. 1H NMR (CDCl
3
, 300 MHz).
Figure 12S. 13C NMR (CDCl
3
, 75 MHz).
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Figure 13S. IR (film).
Figure 14S. 1H NMR (CDCl
3
, 300 MHz) - (S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane (4).
Addition of Chiral and Achiral Allyltrichlorostannanes to Chiral α-Alkoxy Aldehydes J. Braz. Chem. Soc.S14
Figure 15S. 13C NMR (CDCl
3
, 75 MHz) - (S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane (4).
Figure 16S. IR (film) - (S)-(3-(benzyloxy)-2-methylenebutyl)trimethylsilane (4).
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Figure 17S. 1H NMR (CDCl
3
, 300 MHz) - Trimethyl(2-methylenepentadecyl)silane (2).
Figure 18S. 13C NMR (CDCl
3
, 75 MHz) - Trimethyl(2-methylenepentadecyl)silane (2).
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Figure 19S. IR (film) - Trimethyl(2-methylenepentadecyl)silane (2).
Figure 20S. 1H NMR (CDCl
3
, 300 MHz).
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Figure 21S. 13C NMR (CDCl
3
, 63 MHz).
Figure 22S. IR (film).
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Figure 23S. 1H NMR (CDCl
3
, 300 MHz) - (2S,3S)-2-(tert-butyldimethylsilyloxy)hex-5-en-3-ol (13) and (2S,3R)-2-(tert-butyldimethylsilyloxy)hex-5-
en-3-ol (14).
Figure 24S. 13C NMR (CDCl
3
, 75 MHz) - (2S,3S)-2-(tert-butyldimethylsilyloxy)hex-5-en-3-ol (13) and (2S,3R)-2-(tert-butyldimethylsilyloxy)hex-5-
en-3-ol (14).
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Figure 25S. IR (film) - (2S,3S)-2-(tert-butyldimethylsilyloxy)hex-5-en-3-ol (13) and (2S,3R)-2-(tert-butyldimethylsilyloxy)hex-5-en-3-ol (14).
Figure 26S. 1H NMR (CDCl
3
, 300 MHz) - (2S,3S)-2-(tert-butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (15) and (2S,3R)-2-(tert-
butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (16).
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Figure 27S. 13C NMR (CDCl
3
, 63 MHz) - (2S,3S)-2-(tert-butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (15) and (2S,3R)-2-(tert-
butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (16).
Figure 28S. IR (film) - (2S,3S)-2-(tert-butyldimethylsilyloxy)-5-methyleneoctadecan-3-ol (15) and (2S,3R)-2-(tert-butyldimethylsilyloxy)-5-
methyleneoctadecan-3-ol (16).
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Figure 29S. 1H NMR (CDCl
3
, 500 MHz) (2S,3S)-2-(benzyloxy)hex-5-en-3-ol (17) and (2S,3R)-2-(benzyloxy)hex-5-en-3-ol (18).
Figure 30S. 13C NMR (CDCl
3
, 63 MHz) - (2S,3S)-2-(benzyloxy)hex-5-en-3-ol (17) and (2S,3R)-2-(benzyloxy)hex-5-en-3-ol (18).
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Figure 31S. IR (film) - (2S,3S)-2-(benzyloxy)hex-5-en-3-ol (17) and (2S,3R)-2-(benzyloxy)hex-5-en-3-ol (18).
Figure 32S. 1H NMR (CDCl
3
, 300 MHz) - (2S,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (19) and 
(2S,3S,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (20).
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Figure 33S. 13C NMR (CDCl
3
, 75 MHz) - (2S,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (19) and 
(2S,3S,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (20).
Figure 34S. IR (film) - (2S,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (19) and (2S,3S,6R)-7-(benzyloxy)-
2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (20).
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Figure 35S. 1H NMR (CDCl
3
, 300 MHz) - (2S,6R)-7-(benzyloxy)-6-methyl-5-methyleneheptane-2,3-diols (23) and (24).
Figure 36S. 13C NMR (CDCl
3
, 75 MHz) - (2S,6R)-7-(benzyloxy)-6-methyl-5-methyleneheptane-2,3-diols (23) and (24).
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Figure 37S. 1H NMR (CDCl
3
, 300 MHz) - (4R,5S)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (25) and (4S,5S)-4-
((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (26).
Figure 38S. 13C NMR (CDCl
3
, 75 MHz) - (4R,5S)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (25) and (4S,5S)-4-
((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (26).
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Figure 39S. IR (film) - (4R,5S)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (25) and (4S,5S)-4-((R)-4-(benzyloxy)-
3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (26).
Figure 40S. 1H NMR (CDCl
3
, 300 MHz) (2R,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (21) and 
(2R,3S,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (22).
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Figure 41S. 13C NMR (CDCl
3
, 75 MHz) - (2R,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (21) and 
(2R,3S,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (22).
Figure 42S. IR (film) - (2R,3R,6R)-7-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (21) and (2R,3S,6R)-7-(benzyloxy)-
2-(tert-butyldimethylsilyloxy)-6-methyl-5-methyleneheptan-3-ol (22).
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, 500 MHz) - (4R,5R)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (29) and (4S,5R)-4-
((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (30).




, 125 MHz) - (4R,5R)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (29) and (4S,5R)-4-
((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (30).
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Figure 45S. IR (film) - (4R,5R)-4-((R)-4-(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (29) and (4S,5R)-4-((R)-4-
(benzyloxy)-3-methyl-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (30).
Figure 46S. 1H NMR (CDCl
3
, 250 MHz) - (2S,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (31) and (2S,3S,6R)-2,7-bis(benzyloxy)-6-
methyl-5-methyleneheptan-3-ol (32).
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Figure 47S. 13C NMR (CDCl
3
, 63 MHz) - (2S,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (31) and (2S,3S,6R)-2,7-bis(benzyloxy)-6-
methyl-5-methyleneheptan-3-ol (32).
Figure 48S. IR (film) - (2S,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (31) and (2S,3S,6R)-2,7-bis(benzyloxy)-6-methyl-5-
methyleneheptan-3-ol (32).
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Figure 49S. 1H NMR (CDCl
3
, 250 MHz) - (2R,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (33) and (2R,3S,6R)-2,7-bis(benzyloxy)-
6-methyl-5-methyleneheptan-3-ol (34).
Figure 50S. 13C NMR CDCl
3
, 75 MHz) - (2R,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (33) and (2R,3S,6R)-2,7-bis(benzyloxy)-6-
methyl-5-methyleneheptan-3-ol (34).
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Figure 51S. IR (film) - (2R,3R,6R)-2,7-bis(benzyloxy)-6-methyl-5-methyleneheptan-3-ol (33) and (2R,3S,6R)-2,7-bis(benzyloxy)-6-methyl-5-
methyleneheptan-3-ol (34).
Figure 52S. 1H NMR (CDCl
3
, 300 MHz) - (2S,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (35) and (2S,3S,6S)-6-
(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (36).
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, 75 MHz) - (2S,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (35) and (2S,3S,6S)-6-
(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (36).
Figure 54S. IR (film) - (2S,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (35) and (2S,3S,6S)-6-(benzyloxy)-2-(tert-
butyldimethylsilyloxy)-5-methyleneheptan-3-ol (36).
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Figure 55S. 1H NMR (CDCl
3
, 250 MHz) - (2R,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (37) and (2R,3S,6S)-6-
(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (38).
Figure 56S. 13C NMR (CDCl
3
, 63 MHz) - (2R,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (37) and (2R,3S,6S)-6-
(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (38).
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Figure 57S. IR (film) - (2R,3R,6S)-6-(benzyloxy)-2-(tert-butyldimethylsilyloxy)-5-methyleneheptan-3-ol (37) and (2R,3S,6S)-6-(benzyloxy)-2-(tert-
butyldimethylsilyloxy)-5-methyleneheptan-3-ol (38).
Figure 58S. 1H NMR (CDCl
3
, 300 MHz) - (2S,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol (39) and (40).
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Figure 59S. 13C NMR (CDCl
3
, 75 MHz) - (2S,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol (39) and (40).




, 300 MHz) - (4R,5S)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (41) and (4S,5S)-4-((S)-3-
(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (42).
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, 300 MHz) - (4R,5S)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (41) and (4S,5S)-4-((S)-3-
(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (42).
Figure 62S. IR (film) - (4R,5S)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (41) and (4S,5S)-4-((S)-3-(benzyloxy)-2-
methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (42).
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Figure 63S. 1H NMR (CDCl
3
, 300 MHz) - (2R,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol (43) and (44).
Figure 64S. 13C NMR (CDCl
3
, 75 MHz) - (2R,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol (43) and (44).
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Figure 65S. IR (film) - (2R,6S)-6-(benzyloxy)-5-methyleneheptane-2,3-diol (43) and (44).
Figure 66S. 1H NMR (CDCl
3
, 250 MHz) - (4R,5R)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (45) and (4S,5R)-4-((S)-3-
(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (46).
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Figure 67S. 13C NMR (CDCl
3
, 63 MHz) - (4R,5R)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (45) and (4S,5R)-4-((S)-3-
(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (46).
Figure 68S. IR (film) - (4R,5R)-4-((S)-3-(benzyloxy)-2-methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (45) and (4S,5R)-4-((S)-3-(benzyloxy)-2-
methylenebutyl)-2,2,5-trimethyl-1,3-dioxolane (46).
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Figure 69S. 1H NMR (CDCl
3
, 250 MHz) - (2S,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (47) and (2S,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (48).
Figure 70S. 13C NMR (CDCl
3
, 63 MHz) - (2S,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (47) and (2S,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (48).
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Figure 71S. IR (film) - (2S,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (47) and (2S,3S,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (48).
Figure 72S. 1H NMR (CDCl
3
, 250 MHz) - (2R,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (49) and (2R,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (50).
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Figure 73S. 13C NMR (CDCl
3
, 63 MHz) (2R,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (49) and (2R,3S,6S)-2,6-bis(benzyloxy)-5-
methyleneheptan-3-ol (50).
Figure 74S. IR (film) - (2R,3R,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (49) and (2R,3S,6S)-2,6-bis(benzyloxy)-5-methyleneheptan-3-ol (50).
